Redalpine Venture Partners Investors

Redalpine is one of the leading European Venture Capital investors with a focus on highly scalable start-ups. The firm's mission is to help talented entrepreneurs turn an ambitious vision into reality by providing money, experience, coaching, and a strong network. The firm is focused on seed and early-stage investments in disruptivetechnologies in tech and health tech. Redalpine launched its first fund (Redalpine Capital I) in 2007, following the founding partners’ track record of some excellent trade sales and IPOs as serial entrepreneurs and professional angel investors. In 2021 Redalpine closed its sixth fund (Redalpine Capital VI) and currently has approx. USD 1 Billion in AUM. The highly interdisciplinary Redalpine team supports more than 70 portfolio companies with operational and sector-specific expertise and with a rich international network. Redalpine started with its first fund (Redalpine Capital I) in 2007 based on the track-record of some excellent trade-sales and IPOs as serial entrepreneurs and professional angel investors. Redalpine sucessfully launched Redalpine Capital II in 2012 and Redalpine Capital III in 2016. The funds are registered in Luxemburg and backed by dozens of experienced entrepreneurs and investors representing various countries, and a broad range of industries.


Invests into

Founded Date: 2007
Headquarters: Zürich, Zurich, Switzerland
Technology: Drug Discovery
Employee Number: 10-Jan
Industry: Agetech, Precision Medicine
Number Of Exists: 5
Funding Status: N/A
Investor Type: Not Classified
Investment Stage: Early Stage Venture, Seed, Venture